| Global microRNA profiling of pancreatic neuroendocrine neoplasias C Thorns, C Schurmann, N Gebauer, H Wallaschofski, C Kümpers, ... Anticancer research 34 (5), 2249-2254, 2014 | 98 | 2014 |
| TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations N Gebauer, V Bernard, W Gebauer, C Thorns, AC Feller, H Merz Leukemia & lymphoma 56 (1), 179-185, 2015 | 79 | 2015 |
| Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas N Liebers, J Duell, D Fitzgerald, A Kerkhoff, D Noerenberg, E Kaebisch, ... Blood advances 5 (13), 2707-2716, 2021 | 78 | 2021 |
| Clinical, serological, and histopathological similarities between severe COVID-19 and acute exacerbation of connective tissue disease-associated interstitial lung disease (CTD-ILD) D Gagiannis, J Steinestel, C Hackenbroch, B Schreiner, M Hannemann, ... Frontiers in immunology 11, 587517, 2020 | 69 | 2020 |
| Genomic insights into the pathogenesis of Epstein–Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing N Gebauer, A Künstner, J Ketzer, HM Witte, T Rausch, V Benes, ... Blood cancer journal 11 (5), 102, 2021 | 52 | 2021 |
| Prevalence of targetable oncogenic mutations and genomic alterations in Epstein–Barr virus-associated diffuse large B-cell lymphoma of the elderly N Gebauer, J Gebauer, TT Hardel, V Bernard, H Biersack, H Lehnert, ... Leukemia & lymphoma 56 (4), 1100-1106, 2015 | 52 | 2015 |
| Prognostic impact of PD-L1 expression in malignant salivary gland tumors as assessed by established scoring criteria: tumor proportion score (TPS), combined positivity score … HM Witte, N Gebauer, D Lappöhn, VG Umathum, A Riecke, A Arndt, ... Cancers 12 (4), 873, 2020 | 46 | 2020 |
| ID3 mutations are recurrent events in double-hit B-cell lymphomas N Gebauer, V Bernard, AC Feller, H Merz Anticancer research 33 (11), 4771-4778, 2013 | 40 | 2013 |
| Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing A Künstner, HM Witte, J Riedl, V Bernard, S Stölting, H Merz, ... Haematologica 107 (8), 1850, 2021 | 37 | 2021 |
| COVID-19-induced acute respiratory failure–an exacerbation of organ-specific autoimmunity? D Gagiannis, J Steinestel, C Hackenbroch, M Hannemann, V Umathum, ... MedRxiv, 2020.04. 27.20077180, 2020 | 35 | 2020 |
| Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein‐Barr‐Virus positive diffuse large B cell lymphoma HM Witte, H Merz, H Biersack, V Bernard, A Riecke, J Gebauer, H Lehnert, ... British journal of haematology 189 (2), 257-268, 2020 | 28 | 2020 |
| Multidisciplinary late effects clinics for childhood cancer survivors in germany-a two-center Study J Gebauer, S Rieken, S Schuster, B Hahn, N Gebauer, N Meidenbauer, ... Oncology research and treatment 41 (7-8), 430-436, 2018 | 27 | 2018 |
| Genomic landscape of pancreatic neuroendocrine tumors N Gebauer, C Schmidt-Werthern, V Bernard, AC Feller, T Keck, N Begum, ... World Journal of Gastroenterology: WJG 20 (46), 17498, 2014 | 25 | 2014 |
| Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways HM Witte, A Künstner, N Hertel, HW Bernd, V Bernard, S Stölting, H Merz, ... Blood Advances 6 (2), 637-651, 2022 | 23 | 2022 |
| Radiation therapy for metastatic spinal cord compression in patients with hepatocellular carcinoma D Rades, M Dahlke, S Janssen, N Gebauer, T Bartscht in vivo 29 (6), 749-752, 2015 | 21 | 2015 |
| MicroRNA expression and JAK2 allele burden in bone marrow trephine biopsies of polycythemia vera, essential thrombocythemia and early primary myelofibrosis N Gebauer, V Bernard, W Gebauer, AC Feller, H Merz Acta Haematologica 129 (4), 251-256, 2013 | 21 | 2013 |
| Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma N Gebauer, HM Witte, H Merz, I Oschlies, W Klapper, A Caliebe, L Tharun, ... Blood Advances 5 (23), 5220-5225, 2021 | 20 | 2021 |
| Dysregulation of microRNAs in angioimmunoblastic T-cell lymphoma K Reddemann, D Gola, A Schillert, J Knief, C Kuempers, J Ribbat-Idel, ... Anticancer Research 35 (4), 2055-2061, 2015 | 20 | 2015 |
| MicroRNA-150 is up-regulated in extranodal marginal zone lymphoma of MALT type N Gebauer, J Kuba, A Senft, A Schillert, V Bernard, C Thorns Cancer Genomics & Proteomics 11 (1), 51-56, 2014 | 19 | 2014 |
| Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients HM Witte, N Hertel, H Merz, HW Bernd, V Bernard, S Stölting, ... Blood cancer journal 10 (5), 63, 2020 | 18 | 2020 |
